SCHEMBL7381192

SCHEMBL7381192

CCOC(=O)CC(NC(=O)CNC(=O)CCCCNC(=O)OC(C)(C)C)c1cccnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.55
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
ITGB3 P05106 2/20 0.39
ITGAV P06756 2/20 0.39
ITGB5 P18084 2/20 0.39
ITGB6 P18564 2/20 0.39
ITGA2B P08514 1/20 0.39
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
FAAH O00519 1/20 0.37
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
TBXAS1 P24557 1/20 0.36
DRD2 P14416 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7381193 1.00 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C19ITGB3ITGAV
SCHEMBL6737615 0.90 CYP3A4 (0.42) CYP3A4ITGB3ITGA2BGAAALDH1A1
SCHEMBL7379559 0.90 CYP3A4 (0.42) CYP3A4ITGB3ITGA2BGAAALDH1A1
SCHEMBL6952526 0.85 ITGB3 (0.43) CYP3A4CYP2D6CYP2C19ITGB3ITGAV
SCHEMBL7414742 0.85 CYP3A4 (0.47) CYP3A4CYP2D6CYP2C19ITGB3ITGAV
Hydrochloric Acid SCHEMBL7414735 0.84 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C19ITGB3ITGAV
Hydrochloric Acid SCHEMBL7414738 0.84 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C19ITGB3ITGAV
SCHEMBL6949822 0.83 ITGB3 (0.44) CYP3A4CYP2D6CYP2C19ITGB3ITGAV
SCHEMBL8496788 0.80 CYP3A4 (0.64) CYP3A4MAPTFAAHHDAC3HDAC1
SCHEMBL3834572 0.79 SYK (0.44) CYP3A4CYP2D6CYP2C19GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294549-B1 COMPOUNDS USEFUL FOR INHIBITING RESTENOSIS, ANGIOGENESIS, ATHEROSCLEROSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, INFLAMMATION OR TUMOR GROWTH. MERCK & CO., INC. 2001-09-25 US disclosed
EP-0880511-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1999-06-16 EP disclosed
EP-0880511-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-12-02 EP disclosed
WO-1997026250-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1997-07-24 WO disclosed